• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轴促进肺腺癌进展和能量代谢重编程。

axis promotes lung adenocarcinoma progression and energy metabolism reprogramming.

作者信息

Xie Kai, Feng Jian, Fan Dingwei, Wang Shi, Luo Jing, Ren Zhijian, Zheng Chao, Diao Yifei, De Mello Ramon Andrade, Tavolari Simona, Brandi Giovanni, Roden Anja C, Ren Binhui, Shen Yi, Xu Lin

机构信息

Department of Cardiothoracic Surgery, Jinling Hospital, School of Nanjing Medical University, Nanjing, China.

Department of Thoracic Surgery, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing, China.

出版信息

Transl Lung Cancer Res. 2022 Jul;11(7):1405-1419. doi: 10.21037/tlcr-22-465.

DOI:10.21037/tlcr-22-465
PMID:35958341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9359959/
Abstract

BACKGROUND

Metabolic reprogramming is an emerging cancer feature that has recently drawn special attention since it promotes tumor cell growth and proliferation. However, the mechanism of the Warburg effect is still largely unknown. This research aimed to reveal the effects of BarH-like homeobox 2 () in regulating tumor progression and glucose metabolism in lung adenocarcinoma (LUAD).

METHODS

Expression of was measured by quantitative real-time polymerase chain reaction (qRT-PCR) in LUAD cell line and tissues, and the tumor-promoting function of in LUAD cells was detected and xenograft models. The metabolic effects of were examined by detecting glucose uptake, the production levels of lactate and pyruvate, and the extracellular acidification rate (ECAR). Chromatin immunoprecipitation (ChIP) assay and luciferase reporter gene assay were used to identify the underlying molecular mechanism of regulation of . Further studies showed that transcription factor directly interacts with and promotes the transcriptional activity of .

RESULTS

was remarkably up-regulated in LUAD tissues and positively linked to advanced clinical stage and poor prognosis. and data indicated ectopic expression of enhanced cell proliferation and tumorigenesis, whereas knockdown suppressed these effects. Metabolic-related experiments showed promoted the reprogramming of glucose metabolism. Mechanistically, the axis promoted LUAD progression and energy metabolism reprogramming.

CONCLUSIONS

In summary, our research first defined as a tumor-promoting factor in LUAD and that it may act as a novel prognostic biomarker and new therapeutic target for the disease.

摘要

背景

代谢重编程是一种新出现的癌症特征,因其促进肿瘤细胞生长和增殖,最近受到了特别关注。然而,瓦伯格效应的机制仍 largely 未知。本研究旨在揭示类 BarH 同源盒 2()在调节肺腺癌(LUAD)肿瘤进展和葡萄糖代谢中的作用。

方法

通过定量实时聚合酶链反应(qRT-PCR)检测 LUAD 细胞系和组织中 的表达,并在 和 异种移植模型中检测 对 LUAD 细胞的促肿瘤功能。通过检测葡萄糖摄取、乳酸和丙酮酸的产生水平以及细胞外酸化率(ECAR)来研究 的代谢作用。采用染色质免疫沉淀(ChIP)分析和荧光素酶报告基因分析来确定 调控 的潜在分子机制。进一步研究表明,转录因子 直接与 相互作用并促进 的转录活性。

结果

在 LUAD 组织中显著上调,且与晚期临床分期和不良预后呈正相关。 和 数据表明, 的异位表达增强了细胞增殖和肿瘤发生,而 敲低则抑制了这些作用。代谢相关实验表明 促进了葡萄糖代谢的重编程。从机制上讲, 轴促进了 LUAD 的进展和能量代谢重编程。

结论

总之,我们的研究首次将 定义为 LUAD 中的促肿瘤因子,它可能作为该疾病的一种新型预后生物标志物和新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb2/9359959/3bdda56e9445/tlcr-11-07-1405-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb2/9359959/772fc0fbabf1/tlcr-11-07-1405-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb2/9359959/230b64a394e1/tlcr-11-07-1405-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb2/9359959/4be40429ef31/tlcr-11-07-1405-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb2/9359959/a10e16d3c291/tlcr-11-07-1405-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb2/9359959/a444645ec326/tlcr-11-07-1405-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb2/9359959/89d57e5907f0/tlcr-11-07-1405-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb2/9359959/3bdda56e9445/tlcr-11-07-1405-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb2/9359959/772fc0fbabf1/tlcr-11-07-1405-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb2/9359959/230b64a394e1/tlcr-11-07-1405-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb2/9359959/4be40429ef31/tlcr-11-07-1405-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb2/9359959/a10e16d3c291/tlcr-11-07-1405-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb2/9359959/a444645ec326/tlcr-11-07-1405-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb2/9359959/89d57e5907f0/tlcr-11-07-1405-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbb2/9359959/3bdda56e9445/tlcr-11-07-1405-f7.jpg

相似文献

1
axis promotes lung adenocarcinoma progression and energy metabolism reprogramming.轴促进肺腺癌进展和能量代谢重编程。
Transl Lung Cancer Res. 2022 Jul;11(7):1405-1419. doi: 10.21037/tlcr-22-465.
2
Transcription Factor FOXA1 Facilitates Glycolysis and Proliferation of Lung Adenocarcinoma via Activation of TEX19.转录因子 FOXA1 通过激活 TEX19 促进肺腺癌的糖酵解和增殖。
Mol Biotechnol. 2024 Aug;66(8):2144-2154. doi: 10.1007/s12033-023-00848-2. Epub 2023 Aug 22.
3
Downregulation of BarH-like homeobox 2 promotes cell proliferation, migration and aerobic glycolysis through Wnt/β-catenin signaling, and predicts a poor prognosis in non-small cell lung carcinoma.类BarH同源盒蛋白2的下调通过Wnt/β-连环蛋白信号通路促进细胞增殖、迁移及有氧糖酵解,并预示非小细胞肺癌预后不良。
Thorac Cancer. 2018 Mar;9(3):390-399. doi: 10.1111/1759-7714.12593. Epub 2018 Jan 17.
4
circFBXW7 attenuates malignant progression in lung adenocarcinoma by sponging miR-942-5p.环状FBXW7通过吸附miR-942-5p减弱肺腺癌的恶性进展。
Transl Lung Cancer Res. 2021 Mar;10(3):1457-1473. doi: 10.21037/tlcr-21-230.
5
BarH-Like Homeobox 2 Suppresses Cell Proliferation, Invasion, and Angiogenesis in Hepatocellular Carcinoma by Activating N-Acetylgalactosaminyltransferase 4.BarH 样同源盒 2 通过激活 N-乙酰氨基半乳糖胺转移酶 4 抑制肝癌细胞增殖、侵袭和血管生成。
Mol Biotechnol. 2024 Nov;66(11):3226-3237. doi: 10.1007/s12033-023-00930-9. Epub 2023 Nov 13.
6
TRIB3 Promotes Lung Adenocarcinoma Progression via an Enhanced Warburg Effect.TRIB3通过增强瓦伯格效应促进肺腺癌进展。
Cancer Manag Res. 2020 Dec 23;12:13195-13206. doi: 10.2147/CMAR.S287956. eCollection 2020.
7
ESCO2 promotes lung adenocarcinoma progression by regulating hnRNPA1 acetylation.ESCO2 通过调控 hnRNPA1 乙酰化促进肺腺癌进展。
J Exp Clin Cancer Res. 2021 Feb 11;40(1):64. doi: 10.1186/s13046-021-01858-1.
8
LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma.长链非编码 RNA FAM83A-AS1 通过 HIF-1α/糖酵解轴促进肺腺癌的肿瘤增殖和迁移。
Int J Biol Sci. 2022 Jan 1;18(2):522-535. doi: 10.7150/ijbs.67556. eCollection 2022.
9
LncRNA LINC00525 suppresses p21 expression via mRNA decay and triplex-mediated changes in chromatin structure in lung adenocarcinoma.长链非编码 RNA LINC00525 通过 mRNA 衰变和三链体介导的染色质结构改变抑制肺腺癌中 p21 的表达。
Cancer Commun (Lond). 2021 Jul;41(7):596-614. doi: 10.1002/cac2.12181. Epub 2021 Jun 9.
10
Characterization of a Novel LUCAT1/miR-4316/VEGF-A Axis in Metastasis and Glycolysis of Lung Adenocarcinoma.一种新型LUCAT1/miR-4316/VEGF-A轴在肺腺癌转移与糖酵解中的特征分析
Front Cell Dev Biol. 2022 May 13;10:833579. doi: 10.3389/fcell.2022.833579. eCollection 2022.

引用本文的文献

1
Unlocking the secrets of glucose metabolism reprogramming: the role in pulmonary diseases.揭开葡萄糖代谢重编程的秘密:其在肺部疾病中的作用。
Front Pharmacol. 2025 Aug 13;16:1551452. doi: 10.3389/fphar.2025.1551452. eCollection 2025.
2
Toward precision oncology in LUAD: a prognostic model using single-cell sequencing and WGCNA based on a disulfidptosis relative gene signature.迈向肺腺癌的精准肿瘤学:一种基于二硫化物诱导细胞死亡相关基因特征,利用单细胞测序和加权基因共表达网络分析的预后模型。
Front Immunol. 2025 May 21;16:1581915. doi: 10.3389/fimmu.2025.1581915. eCollection 2025.
3
Deciphering the role of PLCD3 in lung cancer: A gateway to glycolytic reprogramming via PKC-Rap1 activation.

本文引用的文献

1
Circular RNA circSHPRH inhibits the malignant behaviors of bladder cancer by regulating the miR-942/BARX2 pathway.环状 RNA circSHPRH 通过调控 miR-942/BARX2 通路抑制膀胱癌的恶性行为。
Aging (Albany NY). 2022 Feb 24;14(4):1891-1909. doi: 10.18632/aging.203911.
2
The hallmarks of cancer metabolism: Still emerging.癌症代谢的特征:仍在不断涌现。
Cell Metab. 2022 Mar 1;34(3):355-377. doi: 10.1016/j.cmet.2022.01.007. Epub 2022 Feb 4.
3
JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles.
解析PLCD3在肺癌中的作用:通过PKC-Rap1激活实现糖酵解重编程的途径。
Heliyon. 2024 Aug 30;10(17):e37063. doi: 10.1016/j.heliyon.2024.e37063. eCollection 2024 Sep 15.
4
Restoring BARX2 in OSCC reverses partial EMT and suppresses metastasis through miR-186-5p/miR-378a-3p-dependent SERPINE2 inhibition.在口腔鳞状细胞癌中恢复 BARX2 通过 miR-186-5p/miR-378a-3p 依赖性 SERPINE2 抑制逆转部分 EMT 并抑制转移。
Oncogene. 2024 Jun;43(25):1941-1954. doi: 10.1038/s41388-024-03053-w. Epub 2024 May 8.
5
Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer.超级增强子在肺癌中作为潜在治疗靶点的致病作用
Front Pharmacol. 2024 Apr 12;15:1383580. doi: 10.3389/fphar.2024.1383580. eCollection 2024.
6
Pancancer analysis of oncogenic BARX2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma.泛癌症分析致癌基因 BARX2,鉴定其在肝肝细胞癌中的预后价值和免疫功能。
Sci Rep. 2023 May 9;13(1):7560. doi: 10.1038/s41598-023-34519-8.
JASPAR 2022:转录因子结合谱开放获取数据库的第 9 个版本。
Nucleic Acids Res. 2022 Jan 7;50(D1):D165-D173. doi: 10.1093/nar/gkab1113.
4
Homeobox Genes in Cancers: From Carcinogenesis to Recent Therapeutic Intervention.癌症中的同源盒基因:从致癌作用到近期的治疗干预
Front Oncol. 2021 Oct 14;11:770428. doi: 10.3389/fonc.2021.770428. eCollection 2021.
5
Lactate in the tumour microenvironment: From immune modulation to therapy.肿瘤微环境中的乳酸:从免疫调节到治疗。
EBioMedicine. 2021 Nov;73:103627. doi: 10.1016/j.ebiom.2021.103627. Epub 2021 Oct 14.
6
Moonlighting functions of metabolic enzymes and metabolites in cancer.代谢酶和代谢物在癌症中的兼职功能。
Mol Cell. 2021 Sep 16;81(18):3760-3774. doi: 10.1016/j.molcel.2021.08.031.
7
A direct negative feedback loop of miR-4721/FOXA1/Nanog promotes nasopharyngeal cell stem cell enrichment and metastasis.miR-4721/FOXA1/Nanog的直接负反馈回路促进鼻咽细胞干细胞富集和转移。
J Transl Med. 2021 Sep 9;19(1):387. doi: 10.1186/s12967-021-03059-y.
8
Metabolic control of cancer progression as novel targets for therapy.癌症进展的代谢控制作为新的治疗靶点
Adv Cancer Res. 2021;152:103-177. doi: 10.1016/bs.acr.2021.06.002. Epub 2021 Jul 12.
9
Lung cancer.肺癌。
Lancet. 2021 Aug 7;398(10299):535-554. doi: 10.1016/S0140-6736(21)00312-3. Epub 2021 Jul 21.
10
Cancer metabolism: looking forward.癌症代谢:展望未来。
Nat Rev Cancer. 2021 Oct;21(10):669-680. doi: 10.1038/s41568-021-00378-6. Epub 2021 Jul 16.